Foresite Capital Management Iv, LLC Rhythm Pharmaceuticals, Inc. Transaction History

Foresite Capital Management Iv, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$19.53 - $25.5 $4.58 Million - $5.98 Million	-234,482 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$18.62 - $24.51 $4.38 Million - $5.76 Million	-235,000 Reduced 50.06%	234,482 $5.06 Million
Q2 2019 Aug 13, 2019	BUY	$21.11 - $28.48 $1.36 Million - $1.84 Million	64,456 Added 15.91%	469,482 $10.3 Million
Q1 2019 May 14, 2019	BUY	$24.76 - $31.66 $124,443 - $159,123	5,026 Added 1.26%	405,026 $11.1 Million
Q4 2018 Feb 13, 2019	SELL	$24.11 - $31.34 $7.16 Million - $9.3 Million	-296,903 Reduced 42.6%	400,000 $10.8 Million
Q3 2018 Nov 13, 2018	SELL	$26.99 - $35.85 $674,750 - $896,250	-25,000 Reduced 3.46%	696,903 $20.3 Million
Q2 2018 Aug 14, 2018	BUY	$17.02 - $35.2 $8.88 Million - $18.4 Million	521,903 Added 260.95%	721,903 $22.6 Million
Q1 2018 May 15, 2018	BUY	$19.9 - $32.25 $497,499 - $806,250	25,000 Added 14.29%	200,000 $3.98 Million
Q4 2017 Feb 13, 2018	BUY	$22.0 - $30.51 $3.85 Million - $5.34 Million	175,000	175,000 $5.09 Million

177

68.5M

467K

224K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $2.74B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iv, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management Iv, LLC with notifications on news.